相似文献
1
Companies balk at California's patent rules for stem cell research.
Nat Med. 2007 Jan;13(1):6. doi: 10.1038/nm0107-6b. Epub 2006 Dec 28.
2
Supporting the work of lesser geniuses: an argument for removing obstructions to human embryonic stem cell research.
Univ Miami Law Rev. 2002 Oct;57(1):157-220.
3
Research interactions between industry and academia: a corporate perspective.
Physiologist. 1996 Jun;39(3):81, 90-2.
4
Australia's bio-regulatory framework: leading the way for stem cell research.
J Biolaw Bus. 2004;7(2):61-4.
5
Ethical questions to ponder in the European stem cell patent debate.
J Biolaw Bus. 2006;9(3):12-6.
6
[Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
Lakartidningen. 2005;102(39):2737.
7
Stem cells: science and society.
Natl Med J India. 2006 Jan-Feb;19(1):47-8.
8
War of words escalates in run-up to California's vote on stem cells.
Nature. 2004 Jul 8;430(6996):125. doi: 10.1038/430125a.
9
Patenting of human embryonic stem cells in Europe.
Biotechnol J. 2009 Apr;4(4):462-4. doi: 10.1002/biot.200900022.
10
The attack of the clones: patent law and stem cell research.
J Law Med. 2003 May;10(4):488-505.
Zotero 插件